New hope for advanced stomach cancer patients in major drug delivery trial
NCT ID NCT07449780
Summary
This study is testing whether giving the drug AK104 as an injection under the skin works as well as giving it through an IV when combined with standard chemotherapy for advanced stomach cancer. The trial will enroll 422 people with advanced stomach or gastroesophageal junction cancer who haven't had previous treatment for their advanced disease. Researchers want to see if the under-the-skin version is as effective and safe as the IV version while potentially being more convenient for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC / GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.